Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 922 of 5804
-
Less may be more: smaller lung surgery tested against standard removal
Disease control Recruiting nowThis study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma ≤ 2 cm with micropapillary and solid subtype negative by intraoperative frozen sections.
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for cancer patients: drug may prevent Chemo-Induced bleeding risk
Disease control CompletedStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Sound waves vs. prostate cancer: new MRI-Guided treatment shows promise
Disease control CompletedPrimary purpose : Evaluation of the efficiency and safety of an alternative global prostate treatment in localized prostate cancer. Primary Objective: Absence of clinically significant cancer (CSC) on control biopsy at 1-year follow-up. Secondary Objectives: 1. Biochemical r…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New Three-Drug cocktail aims to tame relapsed myeloma
Disease control OngoingThis is a Phase I/II study using the combination of twice weekly ixazomib plus pomalidomide and dexamethasone in relapsed and or refractory multiple myeloma (RRMM) patients.
Phase: PHASE1, PHASE2 • Sponsor: Omar Nadeem, MD • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New meningitis vaccine shows promise for toddlers in phase 3 trial
⭐️ VACCINE ⭐️ CompletedPrimary Objective: To demonstrate: * the non-inferiority of the seroprotection rate (antibody titers greater than or equal to \[\>=\] 1:8) to meningococcal serogroup C following the administration of MenACYW Conjugate or Nimenrix® as measured by serum bactericidal assay using h…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 16:55 UTC
-
Experimental CAR-T therapy shows early promise in Tough-to-Treat myeloma
Disease control CompletedThis is a single-center, non-randomized and dose-escalation study to evaluate the safety and efficacy of C-CAR088 in relapsed or refractory multiple myeloma patient.
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill combo aims to improve AML treatment in Non-FLT3 patients
Disease control CompletedRandomized phase II trial to compare the efficacy and safety of standard chemotherapy plus quizartinib versus standard chemotherapy plus placebo in adult patients with newly diagnosed FLT3 wild-type Acute Myeloid Leukemia
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Which diabetes pill is better for Early-Stage patients? major trial compares dapagliflozin and metformin
Disease control CompletedA real-world, nationwide, register-based, randomised trial (RRCT) comparing SGLT2 inhibitors with metformin as standard treatment in early typ 2 diabetes. An open-label trial addressing efficacy with respect to clinically important macro- and microvascular events.
Phase: PHASE4 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New meningitis booster shows promise in phase 3 trial
⭐️ VACCINE ⭐️ CompletedPrimary Objective: To demonstrate the vaccine seroresponse sufficiency of meningococcal serogroups A, C, Y, and W following the administration of a booster dose of meningococcal Polysaccharide (Serogroups A, C, Y and W) Tetanus Toxoid (MenACYW) Conjugate vaccine: * In Group 1 p…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 16:57 UTC
-
Zapping the brain with electricity may restore aging memory
Knowledge-focused CompletedThe research program will evaluate the theoretical claim that age-related memory and cognitive decline in humans result from the inefficient orchestration of rhythmic activity within large-scale cortical networks. The results will contribute to the basic science groundwork for de…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New short radiation regimen aims to cut side effects in breast cancer treatment
Disease control Recruiting nowThe purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS w…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
New daily shot could ease rare hormone disorder
Disease control CompletedDuring the first four weeks of the trial, participants were randomly assigned to one of four groups: three groups received fixed doses of TransCon PTH and one group received placebo. TransCon PTH or placebo were administered as a subcutaneous injection using a pre-filled injectio…
Phase: PHASE2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Freeze and fight: new combo therapy targets melanoma
Disease control CompletedMelanoma is the deadliest form of skin cancer and its incidence has doubled every 20 years in France, where this cancer is responsible of more than 1600 deaths each year. Patients with early diagnosis have good prognosis and can be generally cured by surgery only. Advanced melan…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Hepatitis c donor livers safely transplanted into healthy recipients
Disease control CompletedThis is an open-label, pilot trial to test the safety and efficacy of transplantation of livers from Hepatitis C seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the liver transplant waitlist. Treatment a…
Phase: PHASE2 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hair loss drug shows promise in large global trial
Disease control CompletedThis is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005 (NCT02974868) and B7981015 (NCT…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Major study aims to settle debate on best bladder cancer treatment
Knowledge-focused OngoingBladder cancer is the most common urinary tract cancer and the 5th most common cancer in the US (1). Yet bladder cancer research is underfunded relative to other common cancers. As a result, bladder cancer care is prone to evidence gaps that produce decision uncertainty for both …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Cash for care: nigeria study tests whether money can save mothers and babies
Prevention CompletedIt has been estimated that increasing the use of skilled care during childbirth could prevent up to 1.5 million maternal and newborn deaths and stillbirths by 2025. Conditional cash transfer programs, in which women receive cash payments conditioned on the use of maternal health …
Phase: NA • Sponsor: RAND • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Promising new rabies vaccine passes phase 3 test
Prevention CompletedPrimary Objective: To demonstrate that Purified Vero Rabies Vaccine - Serum Free Vaccine generation 2 (VRVg-2) was non-inferior to Verorab and Imovax Rabies vaccines when co-administered with human rabies immunoglobulin (HRIG), in terms of proportion of participants achieving a …
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 17:51 UTC
-
Vitamin c boosts radiation for sarcoma? early trial shows promise
Disease control CompletedThis is a single-arm open-label phase Ib/II clinical study assessing the efficacy of concurrent high dose ascorbate in combination with radiotherapy in patients with locally advanced, resectable, high grade sarcomas.
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New stent aims to keep leg arteries open longer
Disease control CompletedThe purpose of this study (superiority trial) is to compare the Supera® Peripheral Stent System with a standard nitinol self-expanding stent for treatment of femoro-popliteal arterial occlusive disease. Hypothesis: The Supera® stent is superior to a standard nitinol self-expand…
Phase: NA • Sponsor: Kantonsspital Winterthur KSW • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC